Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of liposomal non-pegylated doxorubicin (TLC D-99) plus ifosfamide in metastatic soft tissue sarcoma
2005-004569-40Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Dec 2006
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vincristine sulfate liposome and ifosfamide in soft tissue sarcoma (STS), sponsored by Humanitas Research Hospital. Started Dec 2006; status: terminated.
02
Drugs
vincristine sulfate liposomeifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2005-004569-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004569-40.